What We Treat
The Barbara and Maurice Deane Prostate Health and Research Center at Mount Sinai’s Department of Urology offers a comprehensive approach to the diagnosis and treatment of prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis to ensure the best possible outcome for each patient. Depending on the diagnosis and the unique needs of each patient, our approach may range from active surveillance (no immediate treatment but close and careful monitoring of the prostate cancer with periodic testing) to a variety of therapies, including the most technologically advanced, minimally invasive treatments. Where appropriate to use, minimally invasive procedures allow for faster recovery times and less postoperative pain.
Our highly skilled surgeons have extensive experience in open, laparoscopic, and robotic-assisted prostatectomy for prostate cancer. We perform hundreds of such procedures annually with superior outcomes and an outstanding safety record. Further, Mount Sinai is one of the few medical centers in the country with physicians trained as minimally invasive surgeons, who are also trained urologic oncologists.
Learn more about our treatment approaches to prostate cancer. An array of minimally-invasive treatment options are available for benign prostatic hyperplasia (BPH) as well, including laser and microwave surgery performed on an outpatient basis. Importantly, our objectives are both for disease cure and preservation of quality-of-life, specifically continence and sexual function. Learn more about our BPH program .
We Can Help
If you would like further information about our program or wish to be evaluated, please call 212-241-4812.